Browse > Article
http://dx.doi.org/10.5483/BMBRep.2015.48.10.044

Antitcoagulant and antiplatelet activities of scolymoside  

Yoon, Eun-Kyung (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Ku, Sae-Kwang (Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University)
Lee, Wonhwa (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Kwak, Soyoung (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Kang, Hyejin (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Jung, Byeongjin (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Bae, Jong-Sup (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Publication Information
BMB Reports / v.48, no.10, 2015 , pp. 577-582 More about this Journal
Abstract
Cyclopia subternata is a medicinal plant commonly used in traditional medicine to relieve pain. Here, the anticoagulant effects of scolymoside, an active compound in C. subternata, were examined by monitoring activated partial thromboplastin time (aPTT), prothrombin time (PT), and the activities of thrombin and activated factor X (FXa). The effects of scolymoside on plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) expression were evaluated in tumor necrosis factor (TNF)-α-activated human endothelial cells. Treatment with scolymoside resulted in prolonged aPTT and PT and the inhibition of thrombin and FXa activities and production. In addition, scolymoside inhibited thrombin-catalyzed fibrin polymerization and platelet aggregation. Scolymoside also elicited anticoagulant effects in mice, including a significant reduction in the PAI-1 to t-PA ratio. Collectively, these findings indicate that scolymoside possesses anticoagulant activities and could be developed as a novel anticoagulant.
Keywords
Coagulation cascade; Endothelium; Fibrinolysis; Scolymoside;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Bae JS (2011) Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem Toxicol 49, 1572-1577   DOI
2 Kim TH, Ku SK and Bae JS (2012) Antithrombotic and profibrinolytic activities of eckol and dieckol. J Cell Biochem 113, 2877-2883   DOI
3 Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D and Poller L (1995) Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 108, 258S-275S   DOI
4 Pereira MS, Melo FR and Mourao PA (2002) Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans? Glycobiology 12, 573-580   DOI
5 Lee W, Yoo H, Ku SK, Kim JA and Bae JS (2013) Anticoagulant activities of piperlonguminine in vitro and in vivo. BMB Rep 46, 484-489   DOI
6 Ku SK and Bae JS (2014) Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo. BMB Rep 47, 376-381   DOI
7 Ku SK and Bae JS (2014) Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa. Arch Pharm Res 37, 1454-1463   DOI
8 Kim SY, Kim S, Kim JM et al (2011) PKC inhibitors RO 31-8220 and Go 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. BMB Rep 44, 140-145   DOI
9 Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J and Wachowicz B (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121, 163-174   DOI
10 Bae JS, Lee W, Nam JO, Kim JE, Kim SW and Kim IS (2014) Transforming Growth Factor beta-induced Protein Promotes Severe Vascular Inflammatory Responses. Am J Respir Crit Care Med 189, 779-786   DOI
11 Ku SK, Han MS, Lee MY, Lee YM and Bae JS (2014) Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. BMB Rep 47, 336-341   DOI
12 Hamaguchi E, Takamura T, Shimizu A and Nagai Y (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 307, 987-994   DOI
13 Davie EW (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 74, 1-6
14 Davie EW, Fujikawa K and Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370   DOI
15 Quinn C, Hill J and Hassouna H (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin Lab Sci 13, 229-238
16 Lopez S, Peiretti F, Bonardo B, Juhan-Vague I and Nalbone G (2000) Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152, 359-366   DOI
17 Lee KH (2000) Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr 3, 515-522   DOI
18 Wells PS, Forgie MA and Rodger MA (2014) Treatment of venous thromboembolism. JAMA 311, 717-728   DOI
19 Despotis GJ, Gravlee G, Filos K and Levy J (1999) Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91, 1122-1151   DOI
20 Jauch EC, Saver JL, Adams HP Jr et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44, 870-947   DOI
21 Leiro JM, Alvarez E, Arranz JA, Siso IG and Orallo F (2003) In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol 65, 1361-1371   DOI
22 Pardo Andreu GL, Maurmann N, Reolon GK et al (2010) Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats. Eur J Pharmacol 635, 124-128   DOI
23 Kazuno S, Yanagida M, Shindo N and Murayama K (2005) Mass spectrometric identification and quantification of glycosyl flavonoids, including dihydrochalcones with neutral loss scan mode. Anal Biochem 347, 182-192   DOI
24 Palomo I, Fuentes E, Padro T and Badimon L (2012) Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med 3, 577-584   DOI
25 Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137, 2493S-2502S
26 Hasler CM, Kundrat S and Wool D (2000) Functional foods and cardiovascular disease. Curr Atheroscler Rep 2, 467-475   DOI
27 Warren CP (1999) Antioxidant effects of herbs. Lancet 353, 676   DOI
28 Philip-Joet F, Alessi MC, Philip-Joet C et al (1995) Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 8, 1352-1356   DOI
29 Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr and Loskutoff DJ (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263, 5797-5803
30 Prior RL and Cao G (1999) Antioxidant capacity and polyphenolic components of teas: implications for altering in vivo antioxidant status. Proc Soc Exp Biol Med 220, 255-261   DOI
31 Joubert E, Joubert ME, Bester C, De Beer D and De Lange JH (2011) Honeybush (Cyclopia spp.): From local cottage industry to global markets - The catalytic and supporting role of research. S A J Bot 77, 889-907
32 Sanchez GM, Re L, Giuliani A, Nunez-Selles AJ, Davison GP and Leon-Fernandez OS (2000) Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 42, 565-573   DOI